Literature DB >> 33877392

The PanSurg-PREDICT Study: Endocrine Surgery During the COVID-19 Pandemic.

K Van Den Heede1, S Chidambaram2, J Winter Beatty2, N Chander3, S Markar2, N S Tolley3,2, F F Palazzo3,2, J K Kinross2, A N Di Marco3,2.   

Abstract

BACKGROUND: In the midst of the COVID-19 pandemic, patients have continued to present with endocrine (surgical) pathology in an environment depleted of resources. This study investigated how the pandemic affected endocrine surgery practice.
METHODS: PanSurg-PREDICT is an international, multicentre, prospective, observational cohort study of emergency and elective surgical patients in secondary/tertiary care during the pandemic. PREDICT-Endocrine collected endocrine-specific data alongside demographics, COVID-19 and outcome data from 11-3-2020 to 13-9-2020.
RESULTS: A total of 380 endocrine surgery patients (19 centres, 12 countries) were analysed (224 thyroidectomies, 116 parathyroidectomies, 40 adrenalectomies). Ninety-seven percent were elective, and 63% needed surgery within 4 weeks. Eight percent were initially deferred but had surgery during the pandemic; less than 1% percent was deferred for more than 6 months. Decision-making was affected by capacity, COVID-19 status or the pandemic in 17%, 5% and 7% of cases. Indication was cancer/worrying lesion in 61% of thyroidectomies and 73% of adrenalectomies and calcium 2.80 mmol/l or greater in 50% of parathyroidectomies. COVID-19 status was unknown at presentation in 92% and remained unknown before surgery in 30%. Two-thirds were asked to self-isolate before surgery. There was one COVID-19-related ICU admission and no mortalities. Consultant-delivered care occurred in a majority (anaesthetist 96%, primary surgeon 76%). Post-operative vocal cord check was reported in only 14% of neck endocrine operations. Both of these observations are likely to reflect modification of practice due to the pandemic.
CONCLUSION: The COVID-19 pandemic has affected endocrine surgical decision-making, case mix and personnel delivering care. Significant variation was seen in COVID-19 risk mitigation measures. COVID-19-related complications were uncommon. This analysis demonstrates the safety of endocrine surgery during this pandemic.

Entities:  

Year:  2021        PMID: 33877392     DOI: 10.1007/s00268-021-06099-z

Source DB:  PubMed          Journal:  World J Surg        ISSN: 0364-2313            Impact factor:   3.352


  19 in total

1.  Research electronic data capture (REDCap)--a metadata-driven methodology and workflow process for providing translational research informatics support.

Authors:  Paul A Harris; Robert Taylor; Robert Thielke; Jonathon Payne; Nathaniel Gonzalez; Jose G Conde
Journal:  J Biomed Inform       Date:  2008-09-30       Impact factor: 6.317

Review 2.  Thyroid cancer in the age of COVID-19.

Authors:  Venessa H M Tsang; Matti Gild; Anthony Glover; Roderick Clifton-Bligh; Bruce G Robinson
Journal:  Endocr Relat Cancer       Date:  2020-11       Impact factor: 5.678

3.  The REDCap consortium: Building an international community of software platform partners.

Authors:  Paul A Harris; Robert Taylor; Brenda L Minor; Veida Elliott; Michelle Fernandez; Lindsay O'Neal; Laura McLeod; Giovanni Delacqua; Francesco Delacqua; Jacqueline Kirby; Stephany N Duda
Journal:  J Biomed Inform       Date:  2019-05-09       Impact factor: 6.317

4.  Response to the Comment on "Reintervention After Antireflux Surgery for Gastroesophageal Reflux Disease in England" Markar et al. Ann Surg 2020;271:709-715.

Authors:  Sheraz R Markar; George B Hanna
Journal:  Ann Surg       Date:  2021-12-01       Impact factor: 12.969

Review 5.  Management changes for patients with endocrine-related cancers in the COVID-19 pandemic.

Authors:  Derek Raghavan; Antoinette R Tan; E Shannon Story; Earle F Burgess; Laura Musselwhite; Edward S Kim; Peter E Clark
Journal:  Endocr Relat Cancer       Date:  2020-09       Impact factor: 5.678

6.  Endocrine surgery during COVID-19 pandemic: do we need an update of indications in Italy?

Authors:  Celestino Pio Lombardi; Annamaria D'Amore; Giorgio Grani; Valeria Ramundo; Mauro Boscherini; Luca Gordini; Federica Marzi; Silvia Tedesco; Raffaella Bocale
Journal:  Endocrine       Date:  2020-06-04       Impact factor: 3.633

7.  Ethical framework for head and neck endocrine surgery in the COVID-19 pandemic.

Authors:  Amy Y Chen; Maisie Shindo
Journal:  Head Neck       Date:  2020-05-13       Impact factor: 3.147

8.  Resuming elective surgery in the time of COVID-19: a safe and comprehensive strategy.

Authors:  Khaled Al-Omar; Sohail Bakkar; Laith Khasawneh; Gianluca Donatini; Paolo Miccoli
Journal:  Updates Surg       Date:  2020-06-03

9.  COVID-19 pandemic: new rules of engagement in endocrine surgery.

Authors:  C P Lombardi; L Gordini; A D'Amore; R Bocale; M Boscherini; R Bellantone
Journal:  Br J Surg       Date:  2020-07-11       Impact factor: 6.939

10.  Elective Cancer Surgery in COVID-19-Free Surgical Pathways During the SARS-CoV-2 Pandemic: An International, Multicenter, Comparative Cohort Study.

Authors:  James C Glasbey; Dmitri Nepogodiev; Joana F F Simoes; Omar Omar; Elizabeth Li; Mary L Venn; Mohammad K Abou Chaar; Vita Capizzi; Daoud Chaudhry; Anant Desai; Jonathan G Edwards; Jonathan P Evans; Marco Fiore; Jose Flavio Videria; Samuel J Ford; Ian Ganly; Ewen A Griffiths; Rohan R Gujjuri; Angelos G Kolias; Haytham M A Kaafarani; Ana Minaya-Bravo; Siobhan C McKay; Helen M Mohan; Keith J Roberts; Carlos San Miguel-Méndez; Peter Pockney; Richard Shaw; Neil J Smart; Grant D Stewart; Sudha Sundar Mrcog; Raghavan Vidya; Aneel A Bhangu
Journal:  J Clin Oncol       Date:  2020-10-06       Impact factor: 44.544

View more
  1 in total

1.  Limited disease progression in endocrine surgery patients with treatment delays due to COVID-19.

Authors:  Reagan A Collins; Catherine DiGennaro; Toni Beninato; Rajshri M Gartland; Natalia Chaves; Jordan M Broekhuis; Lekha Reddy; Jenna Lee; Angelina Deimiller; Maeve M Alterio; Michael J Campbell; Yeon Joo Lee; Tyler K Khilnani; Latoya A Stewart; Mollie A O'Brien; Miguel Valdivia Y Alvarado; Feibi Zheng; David McAneny; Rachel Liou; Catherine McManus; Sophie Y Dream; Tracy S Wang; Tina W Yen; Amal Alhefdhi; Brendan M Finnerty; Thomas J Fahey; Claire E Graves; Amanda M Laird; Matthew A Nehs; Frederick Thurston Drake; James A Lee; Christopher R McHenry; Benjamin C James; Janice L Pasieka; Jennifer H Kuo; Carrie Cunningham Lubitz
Journal:  Surgery       Date:  2022-08-29       Impact factor: 4.348

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.